Lansen Pharmaceutical Holdings Limited 朗生醫藥控股有限公司

• Key Data
• Officers
• Overlaps
• Pay
• Advisers
• Financials

Pay for financial year ended 2022-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

	Name	Last position	Fees	Salary & benefits	Bonus	Retire	Share- based	Total
HKD '000
	Directors
1	Chan, Eliza Ching Har 陳清霞	INED	31					31
2	Chan, Michael Kee Huen 陳記煊	INED	35					35
3	Chen, Li (Lansen Pharmaceutical) 陳力	CEO		532	233			765
4	Horlacher, Fritz Heinrich	INED	4					4
5	Hunt, Stephen Burnau 韓仕德	NED	10					10
6	Liu, Xuezi 劉雪姿	NED		213	216	2		431
7	Wu, Zhentao 吳鎮濤	NED, Ch
8	Yeung, Allen Tak Bun 楊德斌	INED	35					35
9	Zhu, Xun (1958) 朱迅	INED	10					10
	Total		125	745	449	2	0	1,321

Main board pay history

Click on the year-end to see the pay details.

HKD'000

Year-end	Fees	Salary & benefits	Bonus	Retire	Share- based	Total
2022-12-31	125	745	449	2	0	1,321	Report
2021-12-31	140	753	219	14	0	1,126	Report
2020-12-31	109	506	277	11	0	903	Report
2019-12-31	151	461	200	17	0	829	Report
2018-12-31	148	515	176	16	0	855	Report
2016-12-31	141	594	0	16	0	751	Report
2015-12-31	141	298	0	6	0	445	Report
2014-12-31	142	365	0	18	0	525	Report
2013-12-31	100	227	0	51	0	378	Report
2012-12-31	131	330	0	31	0	492	Report
2011-12-31	129	326	0	27	0	482	Report
2010-12-31	100	267	0	25	0	392	Report
Total	1,557	5,387	1,321	234	0	8,499

SGD'000

Year-end	Fees	Salary & benefits	Bonus	Retire	Share- based	Total
2017-12-31	141	333	110	17	0	601	Report
Total	141	333	110	17	0	601

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!

---

Copyright & disclaimer, Privacy policy

Back to top

---